丹诺医药-B(06872)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06872 丹诺医药-B

未开盘 06-04 16:08:11

205.800

+1.400

+0.68%

最高208.600	最低200.200	成交量6.33万
今开205.000	昨收204.400	日振幅4.11%
总市值107.69亿	流通市值107.69亿	总股本5,233万
成交额1,293万	换手率0.12%	流通股本5,233万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06872","market":"HK","secType":"STK","nameCN":"丹诺医药-B","latestPrice":205.8,"timestamp":1780560491725,"preClose":204.4,"halted":0,"volume":63250,"delay":0,"changeRate":0.006849315068493178,"floatShares":52328926,"shares":52328926,"eps":-3.417,"marketStatus":"未开盘","change":1.4,"latestTime":"06-04 16:08:11","open":205,"high":208.6,"low":200.2,"amount":12932385,"amplitude":0.041096,"askPrice":205.8,"askSize":1150,"bidPrice":201,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-3.242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780623000000},"marketStatusCode":0,"adr":0,"listingDate":1779379200000,"exchange":"SEHK","adjPreClose":204.4,"openAndCloseTimeList":[[1780536600000,1780545600000],[1780549200000,1780560000000]],"volumeRatio":0.731298,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06872","defaultTab":"news","newsList":[{"id":"1183051567","title":"丹诺医药-B发布2026年5月股份变动月报，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1183051567","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183051567?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:06","pubTimestamp":1780398379,"startTime":"0","endTime":"0","summary":"丹诺医药(苏州)股份有限公司于2026年6月2日公布了截至2026年5月31日的股份变动月报表。公告显示，公司H股股份于2026年5月22日在香港联合交易所有限公司主板新上市，报告期内股本结构保持稳定。公司同时确认，截至本月底，已符合适用的公众持股量要求。自报告期结束至今，公司未有新增发行及回购活动，股本维持不变。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143533014","title":"异动解读 | 核心产品前景广阔，丹诺医药-B盘中大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143533014","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143533014?lang=zh_cn&edition=full","pubTime":"2026-05-27 11:06","pubTimestamp":1779851217,"startTime":"0","endTime":"0","summary":"丹诺医药-B今日盘中大涨5.94%，引起了市场的广泛关注。消息面上，公司公开发售阶段获得9015.11倍的超额认购，成为今年港股主板超购倍数第二高的新股，显示出市场对其的强烈兴趣。更重要的是，公司的核心产品利福特尼唑是全球首个针对幽门螺杆菌感染的新分子实体候选药物，已于去年8月向国家药监局提交新药上市申请，预计今年底获批。中国幽门螺杆菌感染率约44%，涉及超6亿患者，市场空间极为广阔。此外，公司的另一核心产品利福喹酮注射剂正在推进全球III期临床试验，这是目前唯一处于后期临床开发阶段的人工关节感染小分子候选药物。这些积极进展共同增强了投资者对公司未来发展的信心，推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637391400","title":"港股收评：恒指涨0.86% 科指涨2.11% 科网股普涨 人工智能板块强势 智谱涨超26% 丹诺医药上市首日涨超178%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637391400","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637391400?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:08","pubTimestamp":1779437280,"startTime":"0","endTime":"0","summary":"　　5月19日消息，港股三大指数集体上涨。截至收盘，恒生指数涨0.86%，报25606.03，恒生科技指数涨2.11%，国企指数涨0.89%。盘面上，科网股普涨，联想绩后涨超19%，网易涨超5%，百度、小米、快手涨超1%；半导体板块走强，兆易创新涨超12%；人工智能板块全天强势，智谱涨超26%；今日丹诺医药上市，首日涨超178%。公开发售阶段丹诺医药-B获9015.11倍认购，公开发售的发售股份最终数目为82.81万股股份，占发售股份总数的约9.35%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-05-22/doc-inhyufhk8455118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01024","03032","01810","LU0197773673.USD","LU2226246903.HKD","LU2399975544.HKD","LU0264606111.USD","LU2778985437.USD","LU0791590937.USD","IE00B29SXG58.USD","LU0449515922.USD","LU0052756011.USD","LU0499858602.USD","LU1226287792.SGD","LU0229945570.USD","LU1655091459.SGD","LU0708995583.HKD","BK1521","LU0823397285.USD","LU0345775950.USD","LU0348814723.USD","LU0819121731.USD","LU0501845795.SGD","LU0918141887.USD","LU0449509016.USD","SG9999003461.SGD","LU0052750758.USD","LU0231483743.USD","LU0871576103.HKD","BK1531","LU0823041008.USD","LU0210527791.USD","LU0072913022.USD","LU1226287875.USD","LU1720050803.USD","LU0329678337.USD","LU1961090484.USD","LU0469268626.HKD","SG9999001846.SGD","IE00B031J352.USD","LU0823413660.USD","LU0345776255.USD","LU0463099449.HKD","03115","HSI","LU0049853897.USD","LU0214875030.USD","BK1506","LU0611395673.USD","LU1023057109.AUD","IE00BZ08YR35.GBP","LU1675838814.USD","07552","HK0000320264.USD","09067","SG9999002463.SGD","LU2476274720.SGD","LU0572939691.SGD","LU1868837565.USD","LU0049112450.USD","09088","BK1609","LU0868486357.SGD","LU1282648689.USD","LU1366334578.USD","LU2097828805.USD","LU2279701549.SGD","03423","IE00B031HY20.USD","81024","IE0003795394.USD","LU0630378429.USD","LU1688375341.USD","BK1104","IE0009570106.USD","LU0117844026.USD","XIACY","LU0348827113.USD","LU0593848301.USD","SG9999014674.SGD","LU1868838027.USD","LU0831103253.SGD","LU0898667661.SGD","LU0828237510.HKD","LU2476274308.USD","SG9999002828.SGD","BK1502","03417","LU1267930227.SGD","LU1794554557.SGD","LU0370786039.SGD","LU0235996351.USD","83115","LU0650527681.SGD","BK1588","LU0784639295.USD","LU2097828557.USD","LU0043850808.USD","LU0164872284.USD","LU1366334651.USD","LU0143863784.USD","LU0588546209.SGD","LU1328615791.USD","07226","LU0918141705.HKD","LU0173614495.USD","LU1188198961.HKD","BK1608","IE0034224299.USD","LU0633140560.USD","LU1046422090.SGD","LU0084288322.USD","BK1095","LU0348766576.USD","LU0417516738.SGD","LU0228367735.SGD","BK1589","IE00B3M56506.USD","LU0417516902.SGD","LU1951186391.HKD","IE0032431581.USD","LU0192582467.USD","LU0054450605.USD","LU0327786744.USD","LU0314109678.HKD","LU0456846285.SGD","LU0561508036.HKD","LU1981816686.USD","LU1226288170.HKD","LU0210526637.USD","BK1526","07500","LU2097828714.EUR","82800","LU0163747925.USD","89888","LU0072462343.USD","LU0211977185.USD","BK1590","LU0823426480.USD","LU0762540952.USD","LU1224709979.USD","LU0188438112.USD","LU0531970944.HKD","LU0594300179.USD","09999","LU0348816934.USD","BK1618","LU0531971595.HKD","LU1048596156.SGD","MIUmain","LU0640798160.USD","LU0039217434.USD","LU2087589342.USD","03088","KSTmain","HHImain","LU0359201885.HKD","LU0307460666.USD","00992","513600","BK1575","LU2152927971.USD","IE00B0JY6N72.USD","LU0326950275.SGD","02833","SG9999001051.SGD","LU0823426308.USD","LU0890818403.SGD","LU0823038988.USD","LU1880383440.USD","03419","03037","HK0000306701.USD","BK1587","LU0762541174.USD","LU1115378108.SGD","LU1235295612.USD","02800","02837","IE00B97KM107.HKD","IE0003851619.USD","LU0048580855.USD","LU0051755006.USD","LU0348767384.USD","LU0456827905.SGD","LU0359202008.SGD","LU0572944931.SGD","LU0791591158.USD","LU0856984785.SGD","BK1117","LU1226288253.USD","LU0441854154.USD","BK1607","HXXD.SI","LU0329678170.USD","LU0823413587.USD","IE0008369823.USD","LU1226288097.SGD","LU1807302812.USD","LU0106252389.USD","06872","IE00BZ08YT58.USD","LU0675040207.SGD","LU0683595622.HKD","03067","HK0000320223.HKD","LU0228659784.USD","LU0315179316.USD","LU1770034418.SGD","BK1523","LU1251922891.USD","BIDU","LU0540923850.HKD","LU1719994722.HKD","LU1880383366.USD","LU2039709279.SGD","LU0823397103.USD","LU1785774172.SGD","LU1813983027.USD","MCHmain","LU0287142896.SGD","LU0862451837.USD","LU0862451753.SGD","IE00BZ08YS42.EUR","LU0821914370.USD","LU1481107354.HKD","07300","LU0572940350.SGD","BK1615","LU0630378692.HKD","03033","LU0831093199.SGD","LU0169518387.USD","BK1193","LU0455707207.USD","LU1323998911.USD","LU0823039010.USD","BK1591","LU1956131251.USD","LU2294711473.HKD","LU0164865239.USD","LU0762542818.HKD","IE0032834883.USD","LU0737861772.HKD","LU1303224171.USD","LU0164880469.USD","LU0605514214.HKD","80992","LU0128525689.USD","LU0634319403.HKD","LU0823040885.USD","HSTECH","LU1328277881.USD","LU2097828631.EUR","LU0543330566.HKD","09115","09888","LU0106959298.USD","LU1831875114.USD","IE00B0169L03.USD","LU0633140727.USD","LU2242644610.SGD","07200","LU2257852520.SGD","HK0000306685.HKD","LU1808992512.USD","NTES","LU1048588211.SGD","LU1105468828.SGD","02513","BK1610","IE00B067MR52.USD","LNVGY","LU0254981946.USD","LU1226287529.USD","81810","LU1734074674.USD","LU2097828474.EUR","LU0700851271.USD","LU0359201612.USD","LU0594300419.USD","LU2051468812.USD","LU0149721374.USD","IE0008368742.USD","LU0244354667.USD","LU0737861699.HKD","LU0197773160.USD","LU0499858438.USD","LU0140636845.USD","LU0310800965.SGD","LU0797268264.HKD","IE0031814852.USD","LU0348735423.USD","LU0972618739.USD","HK0000165453.HKD","HK0000286598.CNH","LU0143863198.USD","LU0117841782.USD","LU0431992006.USD","LU0320764599.SGD","LU0502904849.HKD","LU1770036033.HKD","LU0348805143.USD","SG9999001093.SGD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637531362","title":"丹诺医药-B(6872.HK)今日首日在港挂牌上市，股价上涨154%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637531362","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637531362?lang=zh_cn&edition=full","pubTime":"2026-05-22 11:07","pubTimestamp":1779419227,"startTime":"0","endTime":"0","summary":"丹诺医药-B今日首日在港挂牌上市，盘初股价一度上涨154.29%，报192.5港元。据悉，该股在公开发售阶段获9,000倍超额认购，成为今年以来港股主板市场超购倍数第二高的新股。其新药上市申请已于2025年8月获国家药监局受理，预计于2026年底获得批准。另一核心产品利福喹酮注射剂，是全球首个在临床可实现剂量下有望对生物膜感染有效的新分子实体候选药物，亦是目前唯一处于临床开发用于治疗人工关节感染的小分子候选药物。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2be706341f35bf32cdc21f154bd402a1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260522/32246220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637364922","title":"丹诺医药今起上市，手握两大全球首创抗菌新药获国际顶级医药基金AMR重仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2637364922","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637364922?lang=zh_cn&edition=full","pubTime":"2026-05-22 10:30","pubTimestamp":1779417052,"startTime":"0","endTime":"0","summary":"丹诺医药首秀表现出彩。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637552369","title":"新股首日 | 丹诺医药-B涨幅扩大至130%，核心产品利福特尼唑有望年底获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2637552369","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637552369?lang=zh_cn&edition=full","pubTime":"2026-05-22 09:44","pubTimestamp":1779414256,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹诺医药-B首挂上市，公告显示，每股定价75.7港元，共发行885.6万股股份，每手50股，所得款项净额约5.58亿港元。目前，丹诺医药已建立由七项候选药物组成的管线，聚焦尚无或缺乏治疗手段的适应证领域。丹诺医药已于2025年8月向国家药监局提交新药上市申请，该药物有望于2026年底获批。目前，该产品已向国家药监局及美国FDA提交III期多领域临床试验方案。","market":"fut","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2be706341f35bf32cdc21f154bd402a1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444861.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192762179","title":"异动解读｜丹诺医药-B盘中上涨95.24%，上市首日获超9000倍认购火爆开局","url":"https://stock-news.laohu8.com/highlight/detail?id=1192762179","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192762179?lang=zh_cn&edition=full","pubTime":"2026-05-22 09:36","pubTimestamp":1779413784,"startTime":"0","endTime":"0","summary":"5月22日，丹诺医药-B盘中上涨95.24%，报173.6港元，成交额2.11亿港元。消息面上，丹诺医药香港公开发售获9015.11倍认购，市场热度极高。全球幽门螺杆菌治疗市场规模预计至2035年攀升至161亿美元，中国感染率高达44%，涉及超6亿患者，市场空间广阔。丹诺医药于2013年成立，是一家临近商业化阶段的生物科技公司，专注于细菌感染及细菌代谢相关疾病领域创新药研发，已建立由七项创新项目组成的管线。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2be706341f35bf32cdc21f154bd402a1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637369754","title":"港股新股丹诺医药涨近100%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637369754","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637369754?lang=zh_cn&edition=full","pubTime":"2026-05-22 09:30","pubTimestamp":1779413430,"startTime":"0","endTime":"0","summary":"5月22日，截至发稿，港股新股丹诺医药-B(06872.HK)涨98.15%。该公司在公开发售阶段获9015.11倍认购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605223746165377.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"2be706341f35bf32cdc21f154bd402a1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605223746165377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["VXUS","BK4585","BK4588","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133190677","title":"丹诺医药-B香港首秀开盘价剑指150港元，较发行价75.70港元近乎翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1133190677","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133190677?lang=zh_cn&edition=full","pubTime":"2026-05-22 09:22","pubTimestamp":1779412940,"startTime":"0","endTime":"0","summary":"丹诺医药-B的股票在万众瞩目的香港交易所首次亮相中，即将迎来开门红。其开盘价预计将直接冲上每股150港元的高位，这一价格与每股75.70港元的发行定价相比，实现了惊人的翻倍增长，预示着市场对这家生物科技公司的高度热情与强烈信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2be706341f35bf32cdc21f154bd402a1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333621","title":"丹诺医药-B(06872)：香港公开发售获9015.11倍认购 全球发售净筹约5.98亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333621","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637333621?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:48","pubTimestamp":1779364131,"startTime":"0","endTime":"0","summary":"智通财经APP讯，丹诺医药-B(06872)公布配发结果，公司全球发售885.6万股股份，香港公开发售占9.35%，国际发售占90.65%。每股发售价75.7港元，全球发售净筹约5.98亿港元。每手买卖单位50股H股，预期H股将于香港时间2026年5月22日(星期五)上午九时正于联交所开始买卖。其中，香港公开发售获9,015.11倍认购，国际发售获9.24倍认购。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f9e1c127e4dddacca78b723acccd9304","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444679.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131479585","title":"丹诺医药-B超九千倍认购火爆登陆港交所　拟5月22日挂牌筹资约6.70亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1131479585","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131479585?lang=zh_cn&edition=full","pubTime":"2026-05-21 19:46","pubTimestamp":1779364001,"startTime":"0","endTime":"0","summary":"丹诺医药（苏州）股份有限公司完成全球发售，共发行8,856,000股H股，每股发售价75.70港元，预计5月22日登陆香港联交所主板；按发售价计，公司预计总募资约6.70亿港元，扣除相关费用后净筹资金约5.98亿港元。上市后公司已发行股本将增至52,328,926股。上述基石投资者自上市日起计需遵守六个月禁售期，至2026年11月21日方可解除。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f9e1c127e4dddacca78b723acccd9304","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637858873","title":"新股暗盘 | 丹诺医药-B(06872)暗盘盘初涨超89% 每手赚3380港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637858873","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637858873?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:24","pubTimestamp":1779351851,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹诺医药-B(06872)将于5月22日(周五)在香港挂牌。截至发稿，暗盘交易显示报价143.3港元，较招股价75.7港元上涨89.30%，每手50股，不计手续费，每手赚3380港元。盘中，股价一度飙升至155港元，最高涨幅近104.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1444462.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EWH","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134517088","title":"老虎暗盘｜丹诺医药盘初暴涨53%，每手账面赚超2000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134517088","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134517088?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:17","pubTimestamp":1779351426,"startTime":"0","endTime":"0","summary":"公司专注于开发创新药产品。","market":"hk","thumbnail":"https://static.tigerbbs.com/5a6ef712f25ad9047fda16b11faa1ddd","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5a6ef712f25ad9047fda16b11faa1ddd"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ed86ffac74a161b3446a1ae8641b2e6b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2636640020","title":"新股孖展统计 | 5月18日","url":"https://stock-news.laohu8.com/highlight/detail?id=2636640020","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636640020?lang=zh_cn&edition=full","pubTime":"2026-05-18 19:08","pubTimestamp":1779102499,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹诺医药-B(06872)、华曦达(00901)、深演智能(02723)、云英谷科技(03310)正在招股中。截至5月18日，富途证券、老虎国际等券商为丹诺医药借出782.28亿港元，超购逾1246.9倍；为华曦达借出8.9519亿港元，超购逾13.2倍；为深演智能借出18.26亿港元，超购逾35.28倍；为云英谷科技借出13.94亿港元，超购逾11.67倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02723","03310","00901","BK1156","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636701034","title":"一图看懂丹诺医药(6872.HK)IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2636701034","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636701034?lang=zh_cn&edition=full","pubTime":"2026-05-18 09:16","pubTimestamp":1779066995,"startTime":"0","endTime":"0","summary":"一图带您看懂丹诺医药IPO","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/119.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/119.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/4794542","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["IPOS","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636946710","title":"丹诺医药IPO招股，“全球首个”新药有望年底获批｜港股打新","url":"https://stock-news.laohu8.com/highlight/detail?id=2636946710","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636946710?lang=zh_cn&edition=full","pubTime":"2026-05-17 17:29","pubTimestamp":1779010140,"startTime":"0","endTime":"0","summary":"5月16日，丹诺医药开启招股第三天。据Wind数据，丹诺医药将成为2026年以来，继精锋医疗、博瑞生物、德适、迈威生物、英派药业之后，第6家按港交所上市规则第18A章在港挂牌的生物科技公司。丹诺医药-B（06872.HK）公司行业：制药公司简介：丹诺医药成立于2013年，专注于细菌感染及细菌代谢相关疾病领域的创新药研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605173739738610.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605173739738610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","06872","IPOS","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635641085","title":"新股孖展统计 | 5月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635641085","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635641085?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:40","pubTimestamp":1778841628,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，驭势科技(01511)、拓璞数控(07688)结束招股，丹诺医药-B(06872)正在招股中。截至5月15日，富途证券、老虎国际等券商为驭势科技借出2258.72亿港元，超购逾5179.55倍；为拓璞数控借出4991.41亿港元，超购逾2894.08倍；为丹诺医药借出50.67亿港元，超购逾79.83倍。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01511","06872","IPOS","07688"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635704654","title":"全球首创新药“硬实力”领跑，丹诺医药-B(06872)开启招股掘金抗感染赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2635704654","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635704654?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:30","pubTimestamp":1778833820,"startTime":"0","endTime":"0","summary":"5月6日，丹诺医药(苏州)股份有限公司顺利通过港交所主板上市聆讯，并已于5月14日正式开启招股，中信证券、农银国际担任联席保荐人。弗若斯特沙利文数据显示，幽门螺杆菌感染作为全球范围内的高发疾病，2024年全球治疗市场规模69亿美元，预计至2035年将攀升至161亿美元。在幽门螺杆菌感染治疗领域之外，丹诺医药在植入体相关细菌生物膜感染治疗方面同样取得了重要突破。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","06978","BK1574","159992","BK1161","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635727420","title":"严管药店销售司美格鲁肽、替尔泊肽等药品；丹诺医药今起招股","url":"https://stock-news.laohu8.com/highlight/detail?id=2635727420","media":"21世纪经济报道","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635727420?lang=zh_cn&edition=full","pubTime":"2026-05-15 08:01","pubTimestamp":1778803280,"startTime":"0","endTime":"0","summary":"政策导向严管药店销售司美格鲁肽、替尔泊肽等药品据公开资料，近日，江西省药品监督管理局发布《关于进一步加强司美格鲁肽、替尔泊肽等药品流通环节监督管理的通知》，针对在降糖及体重管理方面备受关注的司美格鲁肽、替尔泊肽等药品，强化流通环节监管，保障公众用药安全。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605153738086145.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605153738086145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06872","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635716903","title":"新股孖展统计 | 5月14日","url":"https://stock-news.laohu8.com/highlight/detail?id=2635716903","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635716903?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:39","pubTimestamp":1778755191,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，驭势科技(01511)、拓璞数控(07688)、丹诺医药-B(06872)正在招股中。截至5月14日，富途证券、老虎国际等券商为驭势科技借出783.72亿港元，超购逾1796.53倍；为拓璞数控借出1804.35亿港元，超购逾1045.55倍；为丹诺医药借出12.23亿港元，超购逾18.51倍。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01511","07688","06872"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tennortherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.02},{"period":"1month","weight":1.7186},{"period":"ytd","weight":1.7186}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":-0.0249},{"period":"3month","weight":-0.0196},{"period":"6month","weight":-0.0319},{"period":"1year","weight":0.0676},{"period":"ytd","weight":-0.0147}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丹诺医药（苏州）股份有限公司是一家主要从事发现、开发创新药产品的中国公司。该公司专注于细菌感染和代谢相关疾病领域。该公司的产品包括治疗幽门螺杆菌的新分子实体候选药物利福特尼唑(TNP-2198)、三靶点抗菌候选药物利福喹酮(TNP-2092)注射剂和治疗肠道菌群代谢相关疾病的多靶点抗菌候选药物TNP-2092口服制剂等。","exchange":"SEHK","name":"丹诺医药-B","nameEN":"TENNOR THERAP-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丹诺医药-B(06872)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丹诺医药-B(06872)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丹诺医药-B,06872,丹诺医药-B股票,丹诺医药-B股票老虎,丹诺医药-B股票老虎国际,丹诺医药-B行情,丹诺医药-B股票行情,丹诺医药-B股价,丹诺医药-B股市,丹诺医药-B股票价格,丹诺医药-B股票交易,丹诺医药-B股票购买,丹诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丹诺医药-B(06872)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丹诺医药-B(06872)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}